Testing effectiveness (Phase 2)WithdrawnNCT03733067
What this trial is testing
Safety and Efficacy of Abatacept for Treating Chronic Cytopenia in Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) Haploinsufficiency
Who this might be right for
CTLA4 HaploinsufficencyChronic Cytopenia
National Institute of Allergy and Infectious Diseases (NIAID)